BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24394157)

  • 1. Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices.
    DeCicco AE; Finkel JB; Greenspon AJ; Frisch DR
    Heart Rhythm; 2014 Apr; 11(4):719-24. PubMed ID: 24394157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.
    Cloutier JM; Khoo C; Hiebert B; Wassef A; Seifer CM
    Ther Adv Cardiovasc Dis; 2018 Apr; 12(4):113-122. PubMed ID: 29528778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
    Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
    Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation.
    Boriani G; Pettorelli D
    Vascul Pharmacol; 2016 Aug; 83():26-35. PubMed ID: 27196706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.
    Boriani G; Glotzer TV; Ziegler PD; De Melis M; Mangoni di S Stefano L; Sepsi M; Landolina M; Lunati M; Lewalter T; Camm AJ
    Heart Rhythm; 2018 Mar; 15(3):376-383. PubMed ID: 29122724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review.
    Hess PL; Healey JS; Granger CB; Connolly SJ; Ziegler PD; Alexander JH; Kowey PR; Ruff CT; Flaker G; Halperin JL; Hart RG; Lopes RD
    JAMA Cardiol; 2017 Mar; 2(3):324-331. PubMed ID: 28097334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Ricci RP; Vaccari D; Morichelli L; Zanotto G; Calò L; D'Onofrio A; Curnis A; Pisanò EC; Nangah R; Brieda M; Calzolari V; Melissano D; Rovai N; Gargaro A
    Int J Cardiol; 2016 Sep; 219():251-6. PubMed ID: 27340918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.
    Lau CP; Siu CW; Yiu KH; Lee KL; Chan YH; Tse HF
    Europace; 2015 Oct; 17 Suppl 2():ii40-6. PubMed ID: 26842114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).
    Boriani G; Glotzer TV; Santini M; West TM; De Melis M; Sepsi M; Gasparini M; Lewalter T; Camm JA; Singer DE
    Eur Heart J; 2014 Feb; 35(8):508-16. PubMed ID: 24334432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of device-detected atrial high-rate episodes.
    Tomson TT; Passman R
    Card Electrophysiol Clin; 2015 Sep; 7(3):515-25. PubMed ID: 26304531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving atrial fibrillation detection in patients with implantable cardiac devices by means of a remote monitoring and management application.
    Zoppo F; Facchin D; Molon G; Zanotto G; Catanzariti D; Rossillo A; Baccillieri MS; Menard C; Comisso J; Gentili A; Grammatico A; Bertaglia E; Proclemer A
    Pacing Clin Electrophysiol; 2014 Dec; 37(12):1610-8. PubMed ID: 25113510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device-detected atrial fibrillation: what to do with asymptomatic patients?
    Chen-Scarabelli C; Scarabelli TM; Ellenbogen KA; Halperin JL
    J Am Coll Cardiol; 2015 Jan; 65(3):281-94. PubMed ID: 25614426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial high rate episodes in patients with dual-chamber cardiac implantable electronic devices: unmasking silent atrial fibrillation.
    Benezet-Mazuecos J; Rubio JM; Farré J
    Pacing Clin Electrophysiol; 2014 Aug; 37(8):1080-6. PubMed ID: 24888216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does atrial fibrillation detected by cardiac implantable electronic devices have clinical relevance?
    Glotzer TV; Ziegler PD
    Cardiol Clin; 2014 May; 32(2):271-81. PubMed ID: 24793802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices.
    Solari D; Bertero E; Miceli R; Brunelli C; Ameri P; Canepa M
    Int J Cardiol; 2017 Jun; 236():262-269. PubMed ID: 28143653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting Atrial Fibrillation in the Emergency Department in Patients with Cardiac Implantable Electronic Devices.
    Pugh M; Belott P; Greenwood KL; McNamee PL; Smith B; Craig TL; Mardekian J; Trocio J; Fanning D; Carda E
    J Emerg Med; 2019 Oct; 57(4):437-443. PubMed ID: 31506197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
    Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
    Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is Device-Detected Atrial Fibrillation Actionable?
    Wasserlauf J; Passman RS
    Card Electrophysiol Clin; 2018 Mar; 10(1):75-85. PubMed ID: 29428144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Magnetic Resonance Imaging-Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter-Defibrillator.
    Hopman LHGA; van der Lingen ACJ; van Pouderoijen N; Krabbenborg J; Mulder MJ; Rijnierse MT; Bhagirath P; Robbers LFHJ; van Rossum AC; van Halm VP; Götte MJW; Allaart CP
    J Am Heart Assoc; 2023 Aug; 12(15):e028014. PubMed ID: 37489727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.